FDA Panel Backs Ketamine-like Drug for Depression

Share:
Facebook Twitter Google+

A person holding up a bottle of Ketamin

Despite the panel’s approval, two of five key studies of esketamine failed to meet their primary goals. When taking esketamine, some patients experienced sedation, blood pressure spikes and dissociation (feeling disconnected from surroundings) within two hours of taking the drug, CNN reported.

WebMD Health

Commenti

commenti